Joseph Macaluso
Plus aucun poste en cours
Profil
Joseph P.
Macaluso served as the Chief Financial & Accounting Officer at Electro Catheter Corp.
from 2010 to 2011.
He also held the same position at Tel-Instrument Electronics Corp.
from 2010 to 2012.
Currently, he is the Chief Financial Officer at QXO, Inc. from 2021 to 2024.
Mr. Macaluso completed his undergraduate degree at Fairfield University.
Anciens postes connus de Joseph Macaluso
| Sociétés | Poste | Fin |
|---|---|---|
| QXO, INC. | Directeur Financier/CFO | 06/06/2024 |
| TEL-INSTRUMENT ELECTRONICS CORP. | Directeur Financier/CFO | 07/02/2012 |
Electro Catheter Corp.
 Electro Catheter Corp. Medical SpecialtiesHealth Technology Electro-Catheter Corp. designs, develops, manufactures and markets products utilized in connection with illnesses of the heart and circulatory system and make use of catheters and related products. The company has targeted electrophysiology as its focal area for future growth, but intends to maintain and develop products for the emergency care, invasive and non-invasive cardiology and invasive radiology markets. The company also continues to explore opportunities to expand its Original Equipment Manufacturing business and contract research and development business to capitalize on its catheter technology expertise and its manufacturing capabilities. The Company was founded in 1961 and is headquartered in Rahway, NJ. | Directeur Financier/CFO | 10/01/2011 |
Formation de Joseph Macaluso
| Fairfield University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| TEL-INSTRUMENT ELECTRONICS CORP. | Electronic Technology |
| QXO, INC. | Commercial Services |
| Entreprise privées | 1 |
|---|---|
Electro Catheter Corp.
Electro Catheter Corp. Medical SpecialtiesHealth Technology Electro-Catheter Corp. designs, develops, manufactures and markets products utilized in connection with illnesses of the heart and circulatory system and make use of catheters and related products. The company has targeted electrophysiology as its focal area for future growth, but intends to maintain and develop products for the emergency care, invasive and non-invasive cardiology and invasive radiology markets. The company also continues to explore opportunities to expand its Original Equipment Manufacturing business and contract research and development business to capitalize on its catheter technology expertise and its manufacturing capabilities. The Company was founded in 1961 and is headquartered in Rahway, NJ. | Health Technology |
